Atlas Trials

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Clinical trial NCT02001909 · COMPLETED

Trial details

NCT number
NCT02001909
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2013-12-01
Primary completion
2014-04-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.